Don Imm News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Don Imm. Real-time updates on events, politics, business and more.

ImmuPharma's CEO, Tim McCarthy, presents commercial strategy for lupus drug Lupuzor™ as FDA approves PK study in advance to starting the Phase 3 trial

August 17, 2021

ImmuPharma PLC (AIM:IMM)s (LON:IMM) CEO, Tim McCarthy, presents commercial strategy for lupus drug Lupuzor™ as FDA approves PK study in advance to...

Source: proactiveinvestors.co.uk